T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$2.34B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$1.33B |
| 3 |
Alibaba
BABA
|
+$983M |
| 4 |
Intuit
INTU
|
+$932M |
| 5 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.8B |
| 2 |
Tesla
TSLA
|
+$1.74B |
| 3 |
NXP Semiconductors
NXPI
|
+$1.24B |
| 4 |
Danaher
DHR
|
+$1.21B |
| 5 |
Booking.com
BKNG
|
+$1.09B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.78% |
| 2 | Financials | 16.36% |
| 3 | Consumer Discretionary | 14.69% |
| 4 | Technology | 14.23% |
| 5 | Industrials | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Akamai
AKAM
$18B
| $16.2M | ﹤0.01% |
325,350
-25,320
| -7% | -$1.34M |
|
|
SFE
1227
DELISTED
Safeguard Scientifics, Inc.
SFE
| $16.2M | ﹤0.01% |
1,357,701
+3,000
| +0.2% | +$35.3K |
|
1228
Repligen
RGEN
$9.45B
| $16.2M | ﹤0.01% |
389,788
+63,724
| +20% | +$2.42M |
|
1229
Goodyear
GT
$1.78B
| $16M | ﹤0.01% |
457,521
-8,385
| -2% | -$289K |
|
|
ECHO
1230
EchoStar
ECHO
$26.6B
| $15.9M | ﹤0.01% |
322,943
+40,883
| +14% | +$1.95M |
|
1231
Advance Auto Parts
AAP
$3.46B
| $15.8M | ﹤0.01% |
135,115
| – | – |
|
1232
Generac Holdings
GNRC
$12.8B
| $15.5M | ﹤0.01% |
428,466
+30,961
| +8% | +$1.11M |
|
1233
Stepan Co
SCL
$1.48B
| $15.4M | ﹤0.01% |
177,069
+9,117
| +5% | +$767K |
|
1234
Diageo
DEO
$52.8B
| $15.4M | ﹤0.01% |
128,644
-1,800
| -1% | -$214K |
|
1235
ScottsMiracle-Gro
SMG
$3.59B
| $15.4M | ﹤0.01% |
172,186
+152,287
| +765% | +$13.7M |
|
1236
Heritage Financial
HFWA
$1.23B
| $15.4M | ﹤0.01% |
+580,448
| New | +$14.6M |
|
1237
Zions Bancorporation
ZION
$10.5B
| $15.4M | ﹤0.01% |
350,018
| – | – |
|
|
CBIO
1238
Crescent Biopharma
CBIO
$618M
| $15.2M | ﹤0.01% |
+13,628
| New | +$11.3M |
|
|
GBT
1239
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $15.2M | ﹤0.01% |
+555,826
| New | +$16.5M |
|
1240
Globe Life
GL
$14B
| $15.2M | ﹤0.01% |
198,421
-25,110
| -11% | -$1.91M |
|
1241
Phibro Animal Health
PAHC
$1.38B
| $15.1M | ﹤0.01% |
407,983
+31,363
| +8% | +$1.02M |
|
|
GTS
1242
DELISTED
Triple-S Management Corporation
GTS
| $14.9M | ﹤0.01% |
928,541
-224,827
| -19% | -$3.69M |
|
|
NCOM
1243
DELISTED
National Commerce Corporation
NCOM
| $14.9M | ﹤0.01% |
377,425
+300,100
| +388% | +$11.4M |
|
1244
Nasdaq
NDAQ
$54.6B
| $14.8M | ﹤0.01% |
622,500
-15,990
| -3% | -$368K |
|
1245
TETRA Technologies
TTI
$1.25B
| $14.8M | ﹤0.01% |
5,293,470
+61,330
| +1% | +$204K |
|
|
SRT
1246
DELISTED
Startek Inc.
SRT
| $14.7M | ﹤0.01% |
1,202,623
-103,171
| -8% | -$1.06M |
|
1247
Cheesecake Factory
CAKE
$5.57B
| $14.7M | ﹤0.01% |
292,480
+22,455
| +8% | +$1.33M |
|
|
OTIC
1248
DELISTED
Otonomy, Inc.
OTIC
| $14.7M | ﹤0.01% |
+777,237
| New | +$10.8M |
|
|
TPGE.U
1249
DELISTED
TPG Pace Energy Holdings Corp.
TPGE.U
| $14.6M | ﹤0.01% |
+1,402,514
| New | +$14.4M |
|
1250
Sportsman's Warehouse
SPWH
$46.8M
| $14.5M | ﹤0.01% |
2,677,671
+905,800
| +51% | +$4.56M |
|
Similar funds
T. Rowe Price Associates's Q2 2017 Portfolio in Review
As of Q2 2017, T. Rowe Price Associates held 2,638 positions worth $556B, up 4.2% from $534B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
T. Rowe Price Associates's Q2 2017 filing shows 69 new, 1,185 increased, 969 reduced and 83 closed positions. Its largest new stake was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 15,513,011 shares worth $844M. The largest sale was Amazon, an estimated $1.8B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2017 buy was Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6: 15,513,011 shares worth $844M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2017, an estimated $2.34B increase.
- T. Rowe Price Associates's biggest Q2 2017 reduction was Amazon, cutting an estimated $1.8B.
- T. Rowe Price Associates fully exited Yahoo Inc in Q2 2017, selling an estimated $362M.
- T. Rowe Price Associates's ten largest holdings make up 18% of its $556B portfolio in Q2 2017.
- T. Rowe Price Associates opened 69 new positions and closed 83 in Q2 2017.
- T. Rowe Price Associates's portfolio value rose 4.2% quarter-over-quarter to $556B.
Based on T. Rowe Price Associates's 13F filing for Q2 2017, filed 14 Aug 2017.